| 摘要 |
The invention provides compositions comprising a Histone Deacetylase 6 (HDAC6) inhibitor and an AKT inhibitor, pharmaceutical compositions/formulations and kits of parts comprising the same; optionally further comprising one or more anti-cancer agents. The compositions of the invention provide for surprisingly efficacious killing of inter alia, cancer cells. Thus, the invention also provides for the use of the compositions, pharmaceutical compositions and kits of parts in medicine, and further, for use in the prevention or treatment of cancer and/or neuro-degenerative conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis (ALS), spinal and bulbar muscular atrophy (SbMA), Rubinstein-Taybi syndrome, Rett syndrome, and Friedreich's ataxia, or autoimmune diseases, including Rheumatoid Arthritis, Myasthenia Gravis, and Multiple Sclerosis. |
